| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Muscular Dystrophy, Facioscapulohumeral | 14 | 2024 | 44 | 3.160 |
Why?
|
| Homeodomain Proteins | 11 | 2024 | 272 | 1.430 |
Why?
|
| Muscle, Skeletal | 21 | 2023 | 747 | 1.260 |
Why?
|
| Myoblasts | 6 | 2024 | 64 | 1.210 |
Why?
|
| Trans-Activators | 10 | 2006 | 312 | 1.200 |
Why?
|
| Muscles | 17 | 2003 | 179 | 1.180 |
Why?
|
| Sulfatases | 6 | 2007 | 7 | 1.180 |
Why?
|
| Hedgehog Proteins | 8 | 2013 | 116 | 0.890 |
Why?
|
| Signal Transduction | 20 | 2022 | 3070 | 0.860 |
Why?
|
| Muscle Development | 5 | 2022 | 56 | 0.850 |
Why?
|
| Somites | 6 | 2013 | 13 | 0.770 |
Why?
|
| Gene Expression Regulation, Developmental | 11 | 2006 | 644 | 0.750 |
Why?
|
| MyoD Protein | 12 | 2002 | 45 | 0.750 |
Why?
|
| Cell Differentiation | 17 | 2022 | 1366 | 0.730 |
Why?
|
| Transcription Factors | 10 | 2013 | 1541 | 0.730 |
Why?
|
| Muscle Proteins | 10 | 2004 | 117 | 0.660 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2022 | 154 | 0.650 |
Why?
|
| Protein Aggregation, Pathological | 1 | 2019 | 20 | 0.630 |
Why?
|
| DNA-Binding Proteins | 9 | 2004 | 1197 | 0.610 |
Why?
|
| Myogenic Regulatory Factor 5 | 7 | 2013 | 16 | 0.600 |
Why?
|
| Hyaluronic Acid | 1 | 2019 | 70 | 0.600 |
Why?
|
| Alternative Splicing | 5 | 2017 | 130 | 0.590 |
Why?
|
| Mitochondrial Proteins | 1 | 2019 | 106 | 0.590 |
Why?
|
| Kruppel-Like Transcription Factors | 5 | 2013 | 48 | 0.570 |
Why?
|
| Myosin Heavy Chains | 4 | 2001 | 45 | 0.570 |
Why?
|
| Drosophila | 6 | 2003 | 439 | 0.570 |
Why?
|
| Quail | 7 | 2005 | 9 | 0.570 |
Why?
|
| Animals | 49 | 2024 | 20967 | 0.570 |
Why?
|
| Embryonic Induction | 6 | 2004 | 19 | 0.540 |
Why?
|
| Paired Box Transcription Factors | 5 | 2013 | 16 | 0.520 |
Why?
|
| Stem Cells | 7 | 2022 | 262 | 0.470 |
Why?
|
| Carrier Proteins | 1 | 2019 | 709 | 0.460 |
Why?
|
| Regeneration | 3 | 2022 | 101 | 0.430 |
Why?
|
| Gene Expression Regulation | 12 | 2024 | 1622 | 0.410 |
Why?
|
| Transcriptional Activation | 2 | 2013 | 191 | 0.400 |
Why?
|
| Heparan Sulfate Proteoglycans | 3 | 2007 | 6 | 0.400 |
Why?
|
| Gene Editing | 3 | 2024 | 324 | 0.400 |
Why?
|
| Sulfotransferases | 3 | 2007 | 8 | 0.390 |
Why?
|
| Mice | 22 | 2024 | 11004 | 0.380 |
Why?
|
| Molecular Sequence Data | 14 | 2006 | 1999 | 0.380 |
Why?
|
| Transcription, Genetic | 11 | 2006 | 884 | 0.380 |
Why?
|
| Body Patterning | 4 | 2004 | 82 | 0.380 |
Why?
|
| Cell Line | 7 | 2024 | 2057 | 0.370 |
Why?
|
| Exons | 6 | 2017 | 201 | 0.350 |
Why?
|
| Zebrafish Proteins | 2 | 2003 | 159 | 0.340 |
Why?
|
| Cells, Cultured | 11 | 2022 | 2177 | 0.340 |
Why?
|
| Coturnix | 8 | 1999 | 12 | 0.340 |
Why?
|
| PAX3 Transcription Factor | 4 | 2022 | 12 | 0.330 |
Why?
|
| Mesoderm | 4 | 2004 | 85 | 0.330 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2024 | 172 | 0.310 |
Why?
|
| Protein Kinase C-delta | 2 | 2006 | 8 | 0.310 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2006 | 15 | 0.310 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2006 | 174 | 0.290 |
Why?
|
| RNA, Messenger | 10 | 2012 | 1552 | 0.280 |
Why?
|
| Base Sequence | 11 | 2001 | 1335 | 0.280 |
Why?
|
| Zinc Finger Protein Gli2 | 5 | 2013 | 26 | 0.280 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 2007 | 7 | 0.270 |
Why?
|
| Epigenesis, Genetic | 3 | 2024 | 391 | 0.270 |
Why?
|
| Peripheral Nervous System | 1 | 2007 | 11 | 0.270 |
Why?
|
| Esophagus | 1 | 2007 | 51 | 0.270 |
Why?
|
| Embryonic Development | 2 | 2006 | 137 | 0.260 |
Why?
|
| Amino Acid Sequence | 9 | 2006 | 1597 | 0.260 |
Why?
|
| Neoplasms | 3 | 2006 | 1393 | 0.260 |
Why?
|
| Cell Membrane | 3 | 2005 | 501 | 0.250 |
Why?
|
| Cell Lineage | 4 | 2022 | 273 | 0.250 |
Why?
|
| Humans | 26 | 2024 | 64283 | 0.230 |
Why?
|
| NIH 3T3 Cells | 3 | 2013 | 100 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 210 | 0.220 |
Why?
|
| Conserved Sequence | 4 | 2001 | 173 | 0.220 |
Why?
|
| Deoxyribonucleotides | 1 | 2024 | 13 | 0.220 |
Why?
|
| Genes, Regulator | 3 | 2001 | 28 | 0.220 |
Why?
|
| Zinc Finger Protein GLI1 | 5 | 2006 | 31 | 0.220 |
Why?
|
| Oncogene Proteins | 2 | 2002 | 34 | 0.220 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2024 | 40 | 0.210 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2022 | 152 | 0.210 |
Why?
|
| Xenopus laevis | 1 | 2004 | 68 | 0.210 |
Why?
|
| Cell Proliferation | 2 | 2024 | 1002 | 0.210 |
Why?
|
| Fibroblast Growth Factors | 1 | 2004 | 74 | 0.210 |
Why?
|
| Mutation | 6 | 2024 | 2633 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 1 | 2004 | 104 | 0.200 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2003 | 329 | 0.200 |
Why?
|
| DNA Primers | 3 | 2013 | 295 | 0.200 |
Why?
|
| Proteins | 2 | 1999 | 760 | 0.200 |
Why?
|
| Cloning, Molecular | 6 | 2005 | 386 | 0.190 |
Why?
|
| Flavones | 1 | 2023 | 57 | 0.190 |
Why?
|
| Oxidative Phosphorylation | 1 | 2022 | 41 | 0.190 |
Why?
|
| Gene Expression Profiling | 4 | 2016 | 783 | 0.180 |
Why?
|
| Transfection | 5 | 2005 | 696 | 0.180 |
Why?
|
| Embryo, Nonmammalian | 3 | 2002 | 179 | 0.180 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2019 | 94 | 0.180 |
Why?
|
| DNA, Single-Stranded | 1 | 2022 | 107 | 0.180 |
Why?
|
| Introns | 2 | 2001 | 114 | 0.170 |
Why?
|
| Recovery of Function | 1 | 2022 | 286 | 0.160 |
Why?
|
| Hymecromone | 1 | 2019 | 2 | 0.160 |
Why?
|
| Membrane Proteins | 2 | 2003 | 909 | 0.160 |
Why?
|
| Notochord | 2 | 1998 | 8 | 0.160 |
Why?
|
| Protein Binding | 2 | 2019 | 1619 | 0.160 |
Why?
|
| Myogenic Regulatory Factors | 2 | 1997 | 12 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 3 | 1995 | 110 | 0.160 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 45 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 1 | 2021 | 231 | 0.150 |
Why?
|
| Vertebrates | 1 | 2000 | 44 | 0.150 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2019 | 53 | 0.150 |
Why?
|
| Troponin T | 1 | 1999 | 24 | 0.150 |
Why?
|
| Hermanski-Pudlak Syndrome | 1 | 2019 | 7 | 0.150 |
Why?
|
| Connectin | 1 | 2019 | 14 | 0.150 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 23 | 0.150 |
Why?
|
| Muscular Dystrophies, Limb-Girdle | 1 | 2019 | 16 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2013 | 614 | 0.150 |
Why?
|
| CRISPR-Associated Proteins | 1 | 2019 | 32 | 0.150 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 88 | 0.140 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 2238 | 0.140 |
Why?
|
| Cell Death | 1 | 2019 | 286 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 544 | 0.140 |
Why?
|
| Gene Silencing | 2 | 2016 | 406 | 0.140 |
Why?
|
| Aging | 1 | 2003 | 754 | 0.140 |
Why?
|
| In Situ Hybridization | 5 | 2004 | 216 | 0.140 |
Why?
|
| CRISPR-Cas Systems | 2 | 2022 | 364 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 2017 | 17 | 0.140 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2023 | 268 | 0.140 |
Why?
|
| DNA Transposable Elements | 1 | 1998 | 140 | 0.140 |
Why?
|
| DNA Damage | 1 | 2019 | 289 | 0.140 |
Why?
|
| Heterografts | 2 | 2016 | 66 | 0.130 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1996 | 11 | 0.120 |
Why?
|
| Morpholinos | 1 | 2016 | 52 | 0.120 |
Why?
|
| Philadelphia | 1 | 2015 | 24 | 0.120 |
Why?
|
| Developmental Biology | 1 | 2015 | 6 | 0.120 |
Why?
|
| Genome, Human | 1 | 2017 | 240 | 0.110 |
Why?
|
| Cell Biology | 1 | 2015 | 22 | 0.110 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 102 | 0.110 |
Why?
|
| Golgi Apparatus | 2 | 2005 | 64 | 0.110 |
Why?
|
| Mice, Transgenic | 5 | 2004 | 1297 | 0.110 |
Why?
|
| History, 21st Century | 1 | 2015 | 176 | 0.110 |
Why?
|
| Myosins | 2 | 1991 | 115 | 0.110 |
Why?
|
| DNA, Complementary | 3 | 2005 | 166 | 0.110 |
Why?
|
| Sequence Alignment | 3 | 2001 | 302 | 0.100 |
Why?
|
| Paracrine Communication | 1 | 2013 | 15 | 0.100 |
Why?
|
| History, 20th Century | 1 | 2015 | 235 | 0.100 |
Why?
|
| Genetic Markers | 1 | 2014 | 130 | 0.100 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 65 | 0.100 |
Why?
|
| Phosphorylation | 2 | 2006 | 948 | 0.100 |
Why?
|
| Mice, Mutant Strains | 2 | 2007 | 302 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 128 | 0.100 |
Why?
|
| DNA | 4 | 2022 | 844 | 0.100 |
Why?
|
| Genes | 2 | 1995 | 90 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 146 | 0.100 |
Why?
|
| Carcinogenesis | 1 | 2013 | 131 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 157 | 0.090 |
Why?
|
| CHO Cells | 2 | 2003 | 189 | 0.090 |
Why?
|
| Troponin | 2 | 1990 | 39 | 0.090 |
Why?
|
| Wnt Proteins | 2 | 2003 | 100 | 0.090 |
Why?
|
| Cricetinae | 2 | 2003 | 368 | 0.090 |
Why?
|
| Nerve Tissue Proteins | 3 | 2004 | 429 | 0.090 |
Why?
|
| Heparin | 2 | 2003 | 116 | 0.090 |
Why?
|
| Cell Division | 3 | 2003 | 455 | 0.090 |
Why?
|
| Biomarkers | 3 | 2012 | 1431 | 0.090 |
Why?
|
| Activin Receptors, Type II | 1 | 2011 | 9 | 0.090 |
Why?
|
| Genes, Insect | 3 | 2003 | 90 | 0.090 |
Why?
|
| Myostatin | 1 | 2011 | 16 | 0.080 |
Why?
|
| Neurons | 2 | 2007 | 934 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2023 | 627 | 0.080 |
Why?
|
| Myogenin | 3 | 1996 | 16 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2011 | 174 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2013 | 421 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1997 | 112 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 2016 | 802 | 0.070 |
Why?
|
| Chick Embryo | 3 | 2004 | 46 | 0.070 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 2019 | 81 | 0.070 |
Why?
|
| Animals, Genetically Modified | 3 | 2003 | 302 | 0.070 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2001 | 145 | 0.070 |
Why?
|
| Poly A | 1 | 1987 | 29 | 0.070 |
Why?
|
| Tropomyosin | 1 | 1987 | 37 | 0.070 |
Why?
|
| Neurites | 1 | 2007 | 23 | 0.070 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2007 | 15 | 0.070 |
Why?
|
| Gene Expression | 1 | 2011 | 851 | 0.070 |
Why?
|
| Models, Biological | 3 | 2004 | 1187 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 61 | 0.070 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 674 | 0.070 |
Why?
|
| Neuroglia | 1 | 2007 | 80 | 0.060 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2001 | 495 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1998 | 365 | 0.060 |
Why?
|
| RNA Splicing | 1 | 1987 | 164 | 0.060 |
Why?
|
| Heart | 1 | 1988 | 288 | 0.060 |
Why?
|
| Pregnancy | 1 | 2013 | 2370 | 0.060 |
Why?
|
| Cell Cycle | 2 | 2024 | 396 | 0.060 |
Why?
|
| Chondrogenesis | 1 | 2006 | 9 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2004 | 132 | 0.060 |
Why?
|
| Muscle Contraction | 1 | 2007 | 202 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2006 | 33 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2006 | 46 | 0.060 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2005 | 25 | 0.060 |
Why?
|
| Chickens | 1 | 2006 | 94 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2006 | 94 | 0.060 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2006 | 85 | 0.060 |
Why?
|
| Gene Library | 1 | 2005 | 102 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 230 | 0.060 |
Why?
|
| Substrate Specificity | 1 | 2005 | 340 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 139 | 0.060 |
Why?
|
| Moloney murine leukemia virus | 1 | 2024 | 17 | 0.060 |
Why?
|
| Cell Culture Techniques | 1 | 2006 | 183 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2004 | 100 | 0.050 |
Why?
|
| Oligodendroglia | 1 | 2004 | 36 | 0.050 |
Why?
|
| RNA | 1 | 1987 | 429 | 0.050 |
Why?
|
| Fibroblasts | 1 | 2006 | 404 | 0.050 |
Why?
|
| Myosin Subfragments | 1 | 2003 | 5 | 0.050 |
Why?
|
| Binding, Competitive | 1 | 2003 | 98 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 2003 | 251 | 0.050 |
Why?
|
| Morphogenesis | 2 | 1995 | 114 | 0.050 |
Why?
|
| Female | 6 | 2014 | 33382 | 0.050 |
Why?
|
| Ectoderm | 2 | 2000 | 11 | 0.050 |
Why?
|
| Receptors, Notch | 1 | 2003 | 106 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 2 | 1995 | 460 | 0.050 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2023 | 125 | 0.050 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2023 | 35 | 0.050 |
Why?
|
| Alpharetrovirus | 1 | 2002 | 1 | 0.050 |
Why?
|
| Oncogene Protein p55(v-myc) | 1 | 2002 | 1 | 0.050 |
Why?
|
| K562 Cells | 1 | 2022 | 58 | 0.050 |
Why?
|
| Actins | 2 | 1997 | 261 | 0.050 |
Why?
|
| Drosophila melanogaster | 1 | 2006 | 502 | 0.050 |
Why?
|
| Central Nervous System | 1 | 2004 | 197 | 0.050 |
Why?
|
| Endonucleases | 1 | 2022 | 85 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 112 | 0.040 |
Why?
|
| Mice, Knockout | 3 | 2011 | 2140 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2003 | 343 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2022 | 149 | 0.040 |
Why?
|
| Sarcomeres | 2 | 2003 | 51 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2001 | 98 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2004 | 401 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2023 | 348 | 0.040 |
Why?
|
| Promoter Regions, Genetic | 2 | 1995 | 685 | 0.040 |
Why?
|
| Cell Survival | 2 | 1999 | 582 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2022 | 304 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2004 | 260 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2022 | 432 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2001 | 261 | 0.040 |
Why?
|
| Muscle Fibers, Fast-Twitch | 1 | 1999 | 11 | 0.040 |
Why?
|
| Extremities | 1 | 1999 | 46 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2019 | 29 | 0.040 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2019 | 18 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 1 | 2019 | 23 | 0.040 |
Why?
|
| Male | 3 | 2013 | 30322 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 1999 | 199 | 0.040 |
Why?
|
| Patched Receptors | 1 | 1998 | 10 | 0.040 |
Why?
|
| Drosophila Proteins | 1 | 2003 | 706 | 0.030 |
Why?
|
| Alleles | 1 | 2019 | 449 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 116 | 0.030 |
Why?
|
| beta Catenin | 1 | 2017 | 99 | 0.030 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 324 | 0.030 |
Why?
|
| RNA Probes | 1 | 1996 | 9 | 0.030 |
Why?
|
| Cell Transplantation | 1 | 1996 | 39 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2016 | 77 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 205 | 0.030 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 430 | 0.030 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1995 | 34 | 0.030 |
Why?
|
| Mice, Inbred C3H | 1 | 1995 | 176 | 0.030 |
Why?
|
| Genetic Techniques | 1 | 1995 | 39 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1995 | 196 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 313 | 0.030 |
Why?
|
| Amphibians | 1 | 1993 | 5 | 0.030 |
Why?
|
| Cartilage | 1 | 1993 | 34 | 0.030 |
Why?
|
| Cell Communication | 1 | 1993 | 132 | 0.020 |
Why?
|
| Transcriptome | 1 | 2016 | 396 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2014 | 526 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 11 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1992 | 84 | 0.020 |
Why?
|
| Spine | 1 | 1992 | 50 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2011 | 3450 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 209 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 1991 | 42 | 0.020 |
Why?
|
| Thorax | 1 | 1991 | 34 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2012 | 297 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1991 | 47 | 0.020 |
Why?
|
| Quadriceps Muscle | 1 | 2011 | 14 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 64 | 0.020 |
Why?
|
| Muscular Diseases | 1 | 2011 | 51 | 0.020 |
Why?
|
| Skin | 1 | 1993 | 386 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 901 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1990 | 150 | 0.020 |
Why?
|
| Family | 1 | 2011 | 243 | 0.020 |
Why?
|
| Azacitidine | 1 | 1989 | 15 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1270 | 0.020 |
Why?
|
| Restriction Mapping | 1 | 1988 | 52 | 0.020 |
Why?
|
| Methylation | 1 | 1989 | 131 | 0.020 |
Why?
|
| Oncogenes | 1 | 1989 | 70 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 1989 | 490 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 1176 | 0.020 |
Why?
|
| Disaccharides | 1 | 2007 | 10 | 0.020 |
Why?
|
| Cell Fusion | 2 | 1979 | 39 | 0.020 |
Why?
|
| Myocardium | 1 | 1988 | 288 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 153 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 2605 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 14662 | 0.010 |
Why?
|
| Zinc Finger Protein Gli3 | 1 | 2004 | 9 | 0.010 |
Why?
|
| Adult | 2 | 2012 | 17134 | 0.010 |
Why?
|
| Middle Aged | 2 | 2012 | 17921 | 0.010 |
Why?
|
| Genomic Library | 1 | 2004 | 10 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2004 | 103 | 0.010 |
Why?
|
| Lac Operon | 1 | 2003 | 26 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 133 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 869 | 0.010 |
Why?
|
| Cell Transformation, Viral | 1 | 2002 | 15 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2002 | 99 | 0.010 |
Why?
|
| Binding Sites | 1 | 2004 | 914 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 1223 | 0.010 |
Why?
|
| PAX7 Transcription Factor | 1 | 1999 | 9 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 1979 | 329 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1975 | 8 | 0.010 |
Why?
|
| Valine | 1 | 1975 | 33 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1975 | 190 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1975 | 183 | 0.010 |
Why?
|
| Leucine | 1 | 1975 | 67 | 0.010 |
Why?
|